Khashayar Afshari

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Anti Inflammatory

Liver Metastases

Basal Cell Carcinoma

Top Venues

Fundamental & clinical pharmacology

Scientific reports

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Khashayar Afshari, Erin D Ozturk, Brandon Yates, Glen Picard, J Andrew Taylor
Effect of hybrid FES exercise on body composition during the sub-acute phase of spinal cord injury. PloS one 17 (1) (2022)
Dan Wenzel, Nazgol-Sadat Haddadi, Khashayar Afshari, Jillian M Richmond, Mehdi Rashighi
Upcoming treatments for morphea. Immunity, inflammation and disease 9 (4) (2021)
Keitaro Fukuda, Ken Okamura, Rebecca L Riding, Xueli Fan, Khashayar Afshari, Nazgol-Sadat Haddadi, Sean Matthew McCauley, Mehmet Hakan Guney, Jeremy Luban, Takeru Funakoshi, Tomonori Yaguchi, Yutaka Kawakami, Anastasia Khvorova, Katherine A Fitzgerald, John E Harris
AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma. The Journal of experimental medicine 218 (9) (2021)
Omid Ghamarnejad, Elias Khajeh, Nahid Rezaei, Khashayar Afshari, Ali Adelian, Mohammadsadegh Nikdad, Katrin Hoffmann, Arianeb Mehrabi
Comparative Analysis of the Discriminatory Performance of Different Well-Known Risk Assessment Scores for Extended Hepatectomy. Scientific reports 10 (1) (2020)
Khashayar Afshari, Nazanin Momeni Roudsari, Naser-Aldin Lashgari, Nazgol-Sadat Haddadi, Arvin Haj-Mirzaian, Malihe Hassan Nejad, Hamed Shafaroodi, Mehdi Ghasemi, Ahmad Reza Dehpour, Amir Hossein Abdolghaffari
Antibiotics with therapeutic effects on spinal cord injury: a review. Fundamental & clinical pharmacology 35 (2) (2020)